OTCMKTS:IVOB - Invo Bioscience Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$0.4199 +0.02 (+4.98 %)
(As of 10/17/2018 03:00 AM ET)
Previous Close$0.40
Today's Range$0.3699 - $0.4199
52-Week Range$0.08 - $0.77
Volume28,649 shs
Average Volume58,952 shs
Market Capitalization$64.88 million
P/E RatioN/A
Dividend YieldN/A
Beta-1.1
INVO Bioscience, Inc. provides solutions in assisted reproductive technologies to the reproductive health care community in the United States, Asia, South America, Central America, Europe, the Middle East, India and Africa. The company offers the INVOcell device that is used in infertility treatment for the incubation of eggs and sperm during fertilization, and early embryo development. It also offers INVOcell Retention Device, a single-use, modified diaphragm that includes holes to allow for natural drainage of vaginal fluids; and INVO Holding/Warming Blocks that acts as a tool for viewing and retrieving the embryos from the inner chamber. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors. INVO Bioscience, Inc. is based in Medford, Massachusetts.

Receive IVOB News and Ratings via Email

Sign-up to receive the latest news and ratings for IVOB and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Surgical & medical instruments
Sub-IndustryN/A
SectorMedical
SymbolOTCMKTS:IVOB
CUSIPN/A
Phone978-878-9505

Debt

Debt-to-Equity Ratio-0.04
Current Ratio0.22
Quick Ratio0.21

Price-To-Earnings

Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual Sales$280,000.00
Price / Sales221.14
Cash FlowN/A
Price / CashN/A
Book Value($0.04) per share
Price / Book-10.50

Profitability

EPS (Most Recent Fiscal Year)N/A
Net Income$-700,000.00
Net Margins-539.12%
Return on EquityN/A
Return on Assets-90.11%

Miscellaneous

Employees1
Outstanding Shares147,460,000
Market Cap$64.88 million

Invo Bioscience (OTCMKTS:IVOB) Frequently Asked Questions

What is Invo Bioscience's stock symbol?

Invo Bioscience trades on the OTCMKTS under the ticker symbol "IVOB."

How were Invo Bioscience's earnings last quarter?

Invo Bioscience Inc (OTCMKTS:IVOB) issued its quarterly earnings data on Tuesday, August, 14th. The company reported ($0.01) EPS for the quarter. The company earned $0.11 million during the quarter. View Invo Bioscience's Earnings History.

When is Invo Bioscience's next earnings date?

Invo Bioscience is scheduled to release their next quarterly earnings announcement on Tuesday, November 13th 2018. View Earnings Estimates for Invo Bioscience.

Who are some of Invo Bioscience's key competitors?

Who are Invo Bioscience's key executives?

Invo Bioscience's management team includes the folowing people:
  • Ms. Kathleen T. Karloff, Chairman, CEO & Pres (Age 63)
  • Mr. Robert Joseph Bowdring Jr., Acting CFO, Treasurer, Sec., Consultant & Director (Age 60)
  • Dr. Kevin Doody, Medical Director & Director (Age 56)

How do I buy shares of Invo Bioscience?

Shares of IVOB can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Invo Bioscience's stock price today?

One share of IVOB stock can currently be purchased for approximately $0.4199.

How big of a company is Invo Bioscience?

Invo Bioscience has a market capitalization of $64.88 million and generates $280,000.00 in revenue each year. Invo Bioscience employs 1 workers across the globe.

What is Invo Bioscience's official website?

The official website for Invo Bioscience is http://www.invobioscience.com.

How can I contact Invo Bioscience?

Invo Bioscience's mailing address is 407R MYSTIC AVENUE SUITE 34C, MEDFORD MA, 02155. The company can be reached via phone at 978-878-9505 or via email at [email protected]


MarketBeat Community Rating for Invo Bioscience (OTCMKTS IVOB)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  69 (Vote Outperform)
Underperform Votes:  53 (Vote Underperform)
Total Votes:  122
MarketBeat's community ratings are surveys of what our community members think about Invo Bioscience and other stocks. Vote "Outperform" if you believe IVOB will outperform the S&P 500 over the long term. Vote "Underperform" if you believe IVOB will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel